Healthcare
NextCure, Inc.
NXTCPrice is delayed.
About NextCure, Inc.
NextCure is a drug development company working on medicines to treat cancer and other serious diseases. The company is still in clinical testing stages, meaning its drugs have not yet been approved by regulators. NextCure is developing several different drug candidates, including treatments that work by boosting the body's immune system to fight tumors and others designed to target specific cancer cells. The company also has a drug in development for Alzheimer's disease and another for bone-related conditions like osteoarthritis.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore